Spero (SPRO): Forecast Levels Chart

This price chart illustrates the price action of Spero Therapeutics (SPRO), which focuses on developing new antibiotics. Spero Therapeutics (SPRO) strictly controls chemical utilization to protect the environment, which constitutes 6.00. The firm faces severe pricing pressure and challenges in bringing drugs to market. Business stability relies on regulatory approvals and timely payments from counterparties, provided there are sufficient capital reserves.

SPRO: Spero Price Target Chart 07/04/2022 - 11/11/2026

Analytical breakdowns for Spero (SPRO)

- price and consensus price forecast:

Market Chart sperotherapeutics.com|SPRO - Price Target Chart

- stock exchange capitalization data:

Market Valuation Spero|SPRO - Total Company Value

- balance sheet net asset value indicators:

Accounting Value of a Share Spero Therapeutics|SPRO - Company Book Value|Market-to-Book Ratio sperotherapeutics.com|SPRO - Aggregate Company Assets

- issuer credit burden and liquidity indicators:

Aggregate Debt to Equity Spero Therapeutics|SPRO - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Spero Pharma|SPRO - Company Aggregate Debts|Debts to Book Capitalization Spero|SPRO - Company Long-Term Debt|Company Short-Term Loans and Borrowings Spero Therapeutics|Quick Liquidity Indicator sperotherapeutics.com

- earnings and valuation multiples information:

SPRO - Net Profit|Projected Future Earnings Spero Therapeutics|SPRO - Price to Earnings Ratio|Future Price to Earnings Multiple Spero Therapeutics Inc|SPRO - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Spero|SPRO - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Spero Therapeutics|SPRO - Net earnings per share (EPS TTM)|Year-over-year net earnings per share trend for the last twelve months sperotherapeutics.com|SPRO - Earnings growth in current year|Expected net earnings per share growth next year Spero Therapeutics

General company analysis:SPRO sperotherapeutics.com

The stability of Spero Therapeutics (SPRO) depends on the successful scaling of its antibacterial portfolio through strategic B2B alliances with pharmaceutical behemoths. The price action of the expert-forecasted share price reflects averaged analyst targets, allowing investors to identify the critical gap between market overheating and the business's fundamental value, which makes this chart an indicator of the current trend's validity.

Competitors of Spero Therapeutics